Cargando…

In Vivo Pancreatic β-Cell–Specific Expression of Antiaging Gene Klotho: A Novel Approach for Preserving β-Cells in Type 2 Diabetes

Protein expression of an antiaging gene, Klotho, was depleted in pancreatic islets in patients with type 2 diabetes mellitus (T2DM) and in db/db mice, an animal model of T2DM. The objective of this study was to investigate whether in vivo expression of Klotho would preserve pancreatic β-cell functio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yi, Sun, Zhongjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2015
Materias:	Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375073/ https://www.ncbi.nlm.nih.gov/pubmed/25377875 http://dx.doi.org/10.2337/db14-0632

Ejemplares similares

Antiaging Gene Klotho Attenuates Pancreatic β-Cell Apoptosis in Type 1 Diabetes
por: Lin, Yi, et al.
Publicado: (2015)

Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function
por: Kielgast, Urd, et al.
Publicado: (2011)

Inhibition of 12/15-Lipoxygenase Protects Against β-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes
por: Hernandez-Perez, Marimar, et al.
Publicado: (2017)

Pathobiology of the Klotho Antiaging Protein and Therapeutic Considerations
por: Prud’homme, Gérald J., et al.
Publicado: (2022)

Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
por: Tian, Jide, et al.
Publicado: (2014)

The Putative Role of the Antiageing Protein Klotho in Cardiovascular and Renal Disease
por: Maltese, Giuseppe, et al.
Publicado: (2012)

Insulin Reduces Cerebral Ischemia/Reperfusion Injury in the Hippocampus of Diabetic Rats: A Role for Glycogen Synthase Kinase-3β
por: Collino, Massimo, et al.
Publicado: (2009)

The effects of oxygen tension and antiaging factor Klotho on Wnt signaling in nucleus pulposus cells
por: Hiyama, Akihiko, et al.
Publicado: (2012)

Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes
por: Demeester, Simke, et al.
Publicado: (2015)

Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–Stimulated Adipocytes
por: Serrano-Marco, Lucía, et al.
Publicado: (2011)

Antiaging effects of dietary supplements and natural products
por: Gao, Lulu, et al.
Publicado: (2023)

Reduced Levels of the Antiaging Hormone Klotho are Associated With Increased Aortic Stiffness in Diabetic Kidney Disease
por: Fountoulakis, Nikolaos, et al.
Publicado: (2023)

Restoring Insulin Secretion (RISE): Design of Studies of β-Cell Preservation in Prediabetes and Early Type 2 Diabetes Across the Life Span
Publicado: (2014)

Recommendations for the Definition of Clinical Responder in Insulin Preservation Studies
por: Beam, Craig A., et al.
Publicado: (2014)

The α(2)β(1) integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines
por: Grzesiak, J J, et al.
Publicado: (2006)

Phenotypic Type 2 Diabetes in Obese Youth: Insulin Sensitivity and Secretion in Islet Cell Antibody–Negative Versus –Positive Patients
por: Tfayli, Hala, et al.
Publicado: (2009)

Pancreatic β Cell Mass Death
por: Marrif, Husnia I., et al.
Publicado: (2016)

The Association of Obesity and the Antiaging Humoral Factor Klotho in Middle-Aged and Older Adults
por: Orces, Carlos H.
Publicado: (2022)

Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats: Identification of a Novel Role in Improving Insulin Sensitivity
por: Si, Yiling, et al.
Publicado: (2012)

β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study
por: Meidahl Petersen, Kasper, et al.
Publicado: (2012)

Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes
por: Duan, Franklin F., et al.
Publicado: (2015)

Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes
por: Morgantini, Cecilia, et al.
Publicado: (2011)

Durability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR)
por: Ekström, Nils, et al.
Publicado: (2015)

FGF21 Requires βklotho to Act In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Ephrin-B2–Activated Peripheral Blood Mononuclear Cells From Diabetic Patients Restore Diabetes-Induced Impairment of Postischemic Neovascularization
por: Broquères-You, Dong, et al.
Publicado: (2012)

Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey
por: Gallo, Marco, et al.
Publicado: (2015)

MicroRNA-146a Mimics Reduce the Peripheral Neuropathy in Type 2 Diabetic Mice
por: Liu, Xian Shuang, et al.
Publicado: (2017)

Treatment With Naringenin Elevates the Activity of Transcription Factor Nrf2 to Protect Pancreatic β-Cells From Streptozotocin-Induced Diabetes in vitro and in vivo
por: Rajappa, Rashmi, et al.
Publicado: (2019)

Periodontitis aggravated pancreatic β‐cell dysfunction in diabetic mice through interleukin‐12 regulation on Klotho
por: Liu, Yihua, et al.
Publicado: (2015)

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
por: Sosenko, Jay M., et al.
Publicado: (2020)

Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes
por: Chow, Elaine, et al.
Publicado: (2023)

Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy
por: Qin, Jiang-Jiang, et al.
Publicado: (2018)

Cholesterol Sulfate Exerts Protective Effect on Pancreatic β-Cells by Regulating β-Cell Mass and Insulin Secretion
por: Zhang, Xueping, et al.
Publicado: (2022)

Postprandial Platelet Activation Is Related to Postprandial Plasma Insulin Rather Than Glucose in Patients With Type 2 Diabetes
por: Spectre, Galia, et al.
Publicado: (2012)

Antidopaminergic drugs and acute pancreatitis: a population-based study
por: Bodén, Robert, et al.
Publicado: (2012)

Nerve Growth Factor Gene Therapy Using Adeno-Associated Viral Vectors Prevents Cardiomyopathy in Type 1 Diabetic Mice
por: Meloni, Marco, et al.
Publicado: (2012)

The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes
por: Sims, Emily K., et al.
Publicado: (2021)

Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the Kras(G12D) Mouse Model
por: Gier, Belinda, et al.
Publicado: (2012)

DPP-4 Inhibitor and Sulfonylurea Differentially Reverse Type 2 Diabetes–Induced Blood–Brain Barrier Leakage and Normalize Capillary Pericyte Coverage
por: Elabi, Osama F., et al.
Publicado: (2023)

Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo
por: Konstantopoulos, Nicky, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_76gg7106jf7t6bsbpdncsk3ebb